This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 103 No. 5 May 1999, pp. 1057-1060

AMERICAN ACADEMY OF PEDIATRICS:
Measles Immunization in HIV-Infected Children

Committee on Infectious Diseases and Committee on Pediatric AIDS

Children infected with human immunodeficiency virus (HIV) have had high rates of mortality attributable to measles, but until recently, measles vaccine was assumed to be safe for these children. A single fatal case of pneumonia attributable to vaccine type-measles virus has been documented in a young adult with acquired immunodeficiency syndrome. Because a protective immune response often does not develop in severely immunocompromised HIV-infected patients after immunization and some risk of severe complications exists, HIV-infected children, adolescents, and young adults who are severely immunocompromised (based on age-specific CD4 lymphocyte enumeration) attributable to HIV infection should not receive measles vaccine. All other HIV-infected children, adolescents, and young adults who are not severely immunocompromised should receive measles-mumps-rubella vaccine.

.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Statement of retirement:

AAP Publications Retired or Reaffirmed, October 2006

Pediatrics 119: 405-405. [Full Text]



This article has been cited by other articles:


Home page
 BloodHome page
K. Titanji, A. De Milito, A. Cagigi, R. Thorstensson, S. Grutzmeier, A. Atlas, B. Hejdeman, F. P. Kroon, L. Lopalco, A. Nilsson, et al.
Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection
Blood, September 1, 2006; 108(5): 1580 - 1587.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
S. R. Permar, D. E. Griffin, and N. L. Letvin
Immune Containment and Consequences of Measles Virus Infection in Healthy and Immunocompromised Individuals
Clin. Vaccine Immunol., April 1, 2006; 13(4): 437 - 443.
[Full Text] [PDF]

Home page
 PediatricsHome page
S. M. King, Committee on Pediatric AIDS, and Canadian Paediatric Society, Infectious Diseases a
Evaluation and Treatment of the Human Immunodeficiency Virus-1--Exposed Infant
Pediatrics, August 1, 2004; 114(2): 497 - 505.
[Abstract] [Full Text] [PDF]

Home page
 DTBHome page
MMR vaccine - how effective and how safe?
DTB, April 1, 2003; 41(4): 25 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Red BookHome page
Human Immunodeficiency Virus Infection
Red Book, January 1, 2003; 2003(1): 360 - 382.
[Full Text]

Home page
 Red BookHome page
Measles
Red Book, January 1, 2003; 2003(1): 419 - 429.
[Full Text]

Home page
 Clin. Microbiol. Rev.Home page
P. H. Dennehy
Active Immunization in the United States: Developments over the Past Decade
Clin. Microbiol. Rev., October 1, 2001; 14(4): 872 - 908.
[Abstract] [Full Text] [PDF]